EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Senolytic Changes in Murine Arteriovenous Fistulas with CKD

Jamie Kane iD, Sreenivasulu Kilari iD, Alaura Lemieux iD, Prabh G Singh iD, Nathaniel Anderson iD, Dominik Saul iD, Tamar Tchkonia iD, James L Kirkland iD, Sanjay Misra

Kidney360 · 2026

DOI: 10.34067/kid.0000001104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney360, 2026. Verfasst von Jamie Kane und 8 weiteren Autor:innen. Beteiligte Einrichtung: Vascular and Interventional Radiology Translational Research Lab, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Cellular Senescence, Renal Insufficiency, Chronic, Renal Dialysis. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Heart and Lung Institute, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hemodialysis therapy for end-stage kidney disease (ESKD) requires suitable vascular access, most commonly the arteriovenous fistula (AVF). Forty percent of AVFs fail within one year, leading to morbidity and care costs. Failure mechanisms remain unclear and current therapies are inadequate. Cellular senescence may be critical in AVF failure, and ESKD itself may accelerate senescence and subsequent vascular dysfunction. Senescence follows AVF placement in rodents with normal kidney function, but the temporal and spatial features in uremic conditions are unknown. This study aimed to characterize AVF changes in uremic mice over time and versus control vessels.

Methods

Six- to eight-week-old male C57BL6/J mice underwent 5/6 nephrectomy. Twenty-eight days later an AVF was created by cuff anastomosis (right carotid artery to the right jugular vein). Transcriptomic analysis was performed seven days post-AVF, and further samples were collected at fourteen and twenty-eight days post-AVF creation for histological assessment.

Results

AVF outflow vein morphometry showed reduced neointimal cell density. Whole transcriptomic analysis of outflow vs control veins at seven days post-AVF placement revealed 1187 upregulated and 3256 downregulated genes. Differentially expressed genes were significantly enriched in two established senescence related gene sets, SenMayo (a curated panel of ∼125 genes validated across species to capture senescence and associated proteins) and SenSig (a broader panel assessed to represent fibrotic and stress induced cell response). Histologically, senescence markers p16, p21, and phospho53 increased between day 14 and 28. Genes common to our dataset, SenMayo, and SenSig were validated with qPCR.

Conclusions

These data support established markers of AVF failure like matrix-metalloproteinases and monocyte chemokines and identify potential novel modulators of AVF survival that may inform senolytic strategies to improve patency. In summary, this study reveals for the first time the chronological progression of vascular senescence in the AVF of uremic mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arteriovenous Shunt, SurgicalCellular SenescenceRenal Insufficiency, ChronicRenal DialysisUremiaAnimalsMaleMiceMice, Inbred C57BLDisease Models, AnimalGene Expression ProfilingJugular VeinsCyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p16Tumor Suppressor Protein p53

Stichwörter der Autor:innen

arteriovenous fistulabasic sciencevascular accessvascular disease

Substanzen

Cyclin-Dependent Kinase Inhibitor p21Cyclin-Dependent Kinase Inhibitor p16Tumor Suppressor Protein p53

Autor:innen und Institutionen

  • Vascular and Interventional Radiology Translational Research Lab, Mayo Clinic, Rochester, Minnesota.
  • Kogod Center on Aging and Division of Endocrinology, Mayo Clinic, Rochester, Minnesota.
  • Robert Bosch Center for Tumor Diseases, Stuttgart, Germany.
  • Cedars-Sinai Medical Center, Los Angeles, California.
  • Department of Radiology, Mayo Clinic, Rochester, Minnesota.

ORCID-Profile: Jamie Kane, Sreenivasulu Kilari, Alaura Lemieux, Prabh G Singh, Nathaniel Anderson, Dominik Saul, Tamar Tchkonia, James L Kirkland

Förderung

  • National Heart and Lung Institute
  • NIDDK NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Kane, J., Kilari, S., Lemieux, A., Singh, P. G., Anderson, N., Saul, D., Tchkonia, T., Kirkland, J. L., & Misra, S. (2026). Senolytic Changes in Murine Arteriovenous Fistulas with CKD. Kidney360. https://doi.org/10.34067/kid.0000001104

Vancouver

Kane J, Kilari S, Lemieux A, Singh PG, Anderson N, Saul D, et al. Senolytic Changes in Murine Arteriovenous Fistulas with CKD. Kidney360. 2026. doi:10.34067/kid.0000001104

BibTeX
@article{Kane2026,
  author = {Kane, Jamie and Kilari, Sreenivasulu and Lemieux, Alaura and Singh, Prabh G and Anderson, Nathaniel and Saul, Dominik and Tchkonia, Tamar and Kirkland, James L and Misra, Sanjay},
  title = {Senolytic Changes in Murine Arteriovenous Fistulas with CKD},
  journal = {Kidney360},
  year = {2026},
  doi = {10.34067/kid.0000001104}
}
Kostenlos starten →